INNOVATE BIOPHARMACEUTICALS INC

INNT NASDAQ
1.253
-0.117
-8.56%
Opening 11:52 05/23 EDT
Open
1.370
Prev Close
1.370
High
1.370
Low
1.250
Volume
434.07K
Avg Vol (3M)
991.99K
52 Week High
29.09
52 Week Low
1.250
% Turnover
16.90%
Market Cap
3.22M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers INNOVATE BIOPHARMACEUTICALS INC INNT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and INN-329 (Secretin). The Company’s INN-108 is a novel small molecule comprised of two active parts with anti- inflammatory and immunodulatory properties coupled through an azo bond. The Company is developing INN-108 as a therapeutic for Ulcerative Colitis (UC). Its Secretin stimulated magnetic resonance cholangiopancreatography (MRCP) is a ionizing, radiation-free assessment of the pancreaticobiliary system. The Company has completed a phase II b clinical trial for celiac disease for INN-202. It is developing INN-108 in a phase II trial for inflammatory bowel disorders, mild to moderate UC and a Gastrointestinal (GI) orphan disease.
MORE >

Recently

Name
Price
%Change